Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference
March 03 2015 - 10:00AM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the
Company is scheduled to present a corporate overview at the Cowen
and Company 35th Annual Health Care Conference on Wednesday, March
4, at 8:40 am ET at the Boston Marriott Copley Place Hotel in
Boston, MA.
A live webcast of the presentation will be available online on
the "Events & Presentations" page of the "Investors &
Media" section of the Celldex website. A replay of the presentation
will be available through March 11, 2015.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address
devastating diseases for which available treatments are inadequate.
Our pipeline is built from a proprietary portfolio of antibodies
and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or
suppress the body's immune response. Visit www.celldex.com.
CONTACT: Celldex Company Contacts:
Investors:
Sarah Cavanaugh
Vice President of Investor Relations &
Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
or
Media:
Dan Budwick
Pure Communications, Inc.
(973) 271-6085
dan@purecommunicationsinc.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2023 to Apr 2024